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Activity-dependent gene transcription and protein
synthesis underlie many forms of learning-related
synaptic plasticity. At excitatory glutamatergic
synapses, the immediate early gene product Arc/
Arg3.1 couples synaptic activity to postsynaptic
endocytosis of AMPA-type glutamate receptors.
Although the mechanisms for Arc induction have
been described, little is known regarding the molec-
ular machinery that terminates Arc function. Here, we
demonstrate that the RING domain ubiquitin ligase
Triad3A/RNF216 ubiquitinates Arc, resulting in its
rapid proteasomal degradation. Triad3A associates
with Arc, localizes to clathrin-coated pits, and is
associated with endocytic sites in dendrites and
spines. In the absence of Triad3A, Arc accumulates,
leading to the loss of surface AMPA receptors.
Furthermore, loss of Triad3A mimics and occludes
Arc-dependent forms of synaptic plasticity. Thus,
degradation of Arc by clathrin-localized Triad3A
regulates the availability of synaptic AMPA receptors
and temporally tunes Arc-mediated plasticity at
glutamatergic synapses.
INTRODUCTION
Both long-term synaptic plasticity and behavioral learning
require de novo RNA and protein synthesis (Costa-Mattioli
et al., 2009). Several immediate early genes (IEGs) are rapidly
induced in response to neuronal activity (Flavell and Greenberg,
2008). Among these IEG products, the activity-regulated cyto-
skeleton-associated protein Arc/Arg3.1 is particularly notable,
since its mRNA is rapidly trafficked following neuronal stimula-
tion, where it is locally translated (Lyford et al., 1995; Moga
et al., 2004; Steward et al., 1998). Arc regulates synaptic strength
(Guzowski et al., 2000; Rial Verde et al., 2006; Shepherd et al.,2006; Waung et al., 2008) and promotes the endocytosis of
AMPA receptors at glutamatergic synapses (Rial Verde et al.,
2006; Shepherd et al., 2006; Waung et al., 2008). Indeed, Arc
directly binds dynamin-2 and endophilin-3, which are important
components of the endocytic machinery (Chowdhury et al.,
2006). Recent findings have shown that Arc participates in
multiple forms of synaptic plasticity, including homeostatic
scaling (Gao et al., 2010; Korb et al., 2013; Shepherd et al.,
2006); metabotropic glutamate receptor-dependent long-term
depression (mGluR-LTD) (Jakkamsetti et al., 2013; Park et al.,
2008; Waung et al., 2008); and inverse synaptic tagging, where
it mediates endocytosis of AMPA receptors at inactive synapses
that recently experienced strong stimulation (Okuno et al., 2012).
A large body of work has shown that activity-dependent
endocytosis and AMPA receptor recycling mediate diverse
forms of learning-related synaptic plasticity (Kessels and Mali-
now, 2009; Newpher and Ehlers, 2008). Thus, the transient in-
duction and tight regulation of Arc levels have been proposed
to tune synaptic strength by adjusting postsynaptic trafficking
of AMPA receptors. Notably, once induced, Arc undergoes rapid
protein turnover (Rao et al., 2006), ensuring a discrete temporal
window for Arc-dependent plasticity.
Across phylogeny, protein degradation by the ubiquitin-pro-
teasome system (UPS) regulates many aspects of synapse func-
tion (DiAntonio and Hicke, 2004; Mabb and Ehlers, 2010). At
mammalian hippocampal synapses, long-term alterations in
synaptic activity cause global changes in the composition of
postsynaptic proteins via the UPS (Ehlers, 2003). Furthermore,
long-term potentiation (LTP) at CA1 synapses in the hippocam-
pus requires a balance between protein synthesis and proteaso-
mal degradation (Fonseca et al., 2006), suggesting that newly
synthesized plasticity proteins are subject to ubiquitin-depen-
dent turnover for reliable synapse function. Additionally, a variety
of activity-induced proteins, including Arc, are degraded by the
UPS (Greer et al., 2010; Rao et al., 2006). However, the mecha-
nisms by which Arc is targeted for UPS degradation and how Arc
turnover is coupled to endocytic function remain poorly defined.
In the present study, we demonstrate that the RING domain
E3 ubiquitin ligase Triad3A/RNF216 ubiquitinates Arc and pro-
motes its proteasomal degradation. Using live-cell imaging andNeuron 82, 1299–1316, June 18, 2014 ª2014 Elsevier Inc. 1299
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Figure 1. Rapid Turnover of Arc and Interaction with the RING E3 Ligase Triad3A
(A) Pulse-chase analysis of endogenous Arc. Cortical neurons at 14–18 days in vitro (DIV14–18) were treated with 40 mM 4AP and 50 mM Bic for 4 hr in the
presence of 35S-Cys/Met. Labeled neurons were chased with unlabeled amino acids for various times in the continued presence of 4AP/Bic. Cell lysates were
immunoprecipitated with an anti-Arc antibody, resolved by SDS-PAGE, and visualized by autoradiography. The remaining labeled Arc was plotted over time.
Data indicate means ± SEM and half-life (t1/2) is shown. n = 3. IB, immunoblot.
(B) Endogenous Arc is upregulated and ubiquitinated upon 4AP/Bic treatment. DIV14 cortical neurons were incubated with 4AP/Bic for 1 and 4 hr. Endogenous
Arc was immunoprecipitated (IP) under denaturing conditions, resolved by SDS-PAGE, and immunoblotted (IB) with an anti-ubiquitin (Ub) antibody. Brackets
indicate polyubiquitinated Arc species.
(C) Arc is ubiquitinated in vivo. Hippocampal extracts were isolated from mice following pilocarpine-induced seizures to elevate Arc levels. Endogenous ubiq-
uitinated Arc was immunoprecipitated (IP) and detected as in (B). Brackets indicate polyubiquitinated Arc species. IB, immunoblot.
(D) Identification of Triad3A as a binding partner of Arc by yeast two-hybrid screening. Schematic diagram indicates domain structures of Arc and Triad3A and
their identified binding regions. Numbers indicate amino acid residues. CC, coiled-coil domain; EB, endophilin-3 binding domain; SRH, spectrin repeat homology
domain; RING, Really Interesting New Gene domain; IBR, In-Between-RING domain.
(legend continued on next page)
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Triad3A Ubiquitinates Arcbiochemical analysis, we show that Triad3A localizes to clathrin-
coated pits and controls Arc turnover. Overexpression of
Triad3A reduces levels of Arc, resulting in an increased abun-
dance of synaptic AMPA receptors. Conversely, loss of Triad3A
leads to elevated Arc levels and downregulation of AMPA
receptors. Furthermore, overexpression of Triad3A prevents
homeostatic synaptic scaling and mGluR-dependent synaptic
depression, whereas in the absence of Triad3A, these
Arc-dependent forms of synaptic plasticity are mimicked and
occluded. Thus, degradation of Arc by clathrin-localized Triad3A
regulates synaptic strength by limiting the endocytic trafficking
of AMPA receptors. Such spatial control of protein degradation
at synapses provides a mechanism for limiting the duration of
plasticity protein action in response to bouts of activity.
RESULTS
Proteasomal Degradation Regulates Arc Turnover
in Neurons
The translation of Arc mRNA is rapidly induced by synaptic
activity in an N-methyl-D-aspartate receptor-dependent manner
in vivo (Lyford et al., 1995; Steward and Worley, 2001). We
recapitulated this manipulation in vitro by treating cultured
hippocampal neurons with 4-aminopyridine (4AP), a blocker of
Kv1 family K
+ channels, together with the g-aminobutyric acid
(GABA) receptor antagonist bicuculline (4AP/Bic), to enhance
synaptic and network activity (Kawashima et al., 2009). Using
this protocol, Arc protein expression is robustly induced (Fig-
ure S1A available online) (Kawashima et al., 2009). The 4AP/
Bic-induced increase in Arc protein was prevented by the Na+
channel blocker tetrodotoxin (TTX; 2 mM) (Figure S1A). Following
its induction by 4AP/Bic, Arc protein rapidly decays in the pres-
ence of protein synthesis inhibitors (Figure S1A), indicating the
robust degradation of newly synthesized Arc. To measure the
half-life of newly synthesized Arc following increased neuronal
activity, we performed pulse-chase metabolic labeling experi-
ments in cortical neurons. Newly synthesized Arc was radiola-
beled with 35S-cysteine/methionine (35S-Cys/Met) under condi-
tions of elevated activity (4AP/Bic). Neurons were then chased
by incubation with unlabeled amino acids over time (Figure 1A).
With elevated synaptic activity, we observed robust induction,
followed by a rapid decay of labeled Arc protein. The half-life
of newly synthesized Arc protein was 45 ± 10 min (Figure 1A),
which is consistent with previous observations (Rao et al., 2006).
To test whether the rapid degradation of Arc is mediated by
the UPS, we incubated cortical neurons with the proteasome
inhibitor MG132 (30 mM, 1 hr), following treatment with 4AP/
Bic. In addition to the induction of Arc protein by synaptic activity
(3-fold induction compared to TTX, p < 0.05), Arc levels were(E) Subcellular distribution of Triad3A in brain. Subcellular fractions from adult ra
lane, 25 mg of S1, P2, and P3 fractions, or 8 mg each of total synaptosomal plasma
PSDIII) were loaded for immunoblot analysis. Note that Triad3A is present in bot
(F) Triad3A and Arc form a complex in heterologous cells. FLAG-Triad3A andmyc-A
to their corresponding epitope tags (myc, left; Flag, right), followed by immunoblot
corresponding coimmunoprecipitation of Triad3A or Arc. h.c., immunoglobulin G (
(G) In vivo interaction of endogenous Arc and Triad3A in mouse hippocampus. F
were immunoprecipitated (IP) with an anti-Triad3A antibody, and precipitated prfurther augmented upon treatment with MG132 (Figures S1B
and S1C; 1.5-fold relative to 4AP/Bic alone, p < 0.05). We also
observed increased Arc levels on MG132 treatment by immu-
nocytochemical staining of hippocampal neurons (Figures S1D
and S1E). Endogenous Arc protein was robustly induced and
ubiquitinated in cortical neurons following treatment with 4AP/
Bic (Figure 1B). A similar increase in total and ubiquitinated
Arc occurred in mouse hippocampus in vivo following seizure
induction using pilocarpine (Figure 1C). Thus, upon increased
activity, Arc protein is rapidly synthesized but then quickly
degraded by the UPS both in vitro and in vivo.
Triad3A/RNF216 Interacts with Arc and Promotes
Its Ubiquitination
To identify binding partners that regulate Arc degradation, we
performed a yeast two-hybrid screen using full-length Arc as
bait against a mouse brain complementary DNA (cDNA) library.
We identified a strong interaction between Arc and the RING
domain E3 ubiquitin ligase Triad3A/RNF216 (Figure S1F). Anal-
ysis of isolated clones mapped the interaction to the N-terminal
domain of Triad3A upstream of the RING-IBR-RING domain
(amino acids 201–470) and the C-terminal domain of Arc
encompassing the spectrin-like homology repeats (amino acids
94–382) (Figure 1D). Triad3A was initially identified as a RING
domain ubiquitin E3 ligase involved in the ubiquitination of
toll-like receptors (Chuang and Ulevitch, 2004). Triad3A is
the major splice variant of Triad3, which encodes five splice
variants, Triad3A–Triad3E (Chuang and Ulevitch, 2004). Among
these splice variants, Triad3A is most highly expressed in
brain (Chuang and Ulevitch, 2004), including hippocampus,
neocortex, olfactory bulb, and cerebellum (Figures S1G and
S1H). Biochemical fractionation indicated the presence of
Triad3A protein in both presynaptic vesicle (S3) and post-
synaptic density (PSD) fractions, although abundance in the
PSD fraction was lower (Figure 1E). When coexpressed in
HEK293T cells, myc-tagged Arc coimmunoprecipitated with
Flag-tagged Triad3A and vice versa (Figure 1F). In addition,
endogenous Arc protein coimmunoprecipitated with Triad3A
from hippocampal extracts of mice on induction of Arc by pilo-
carpine-induced seizures (Figure 1G).
After transfecting human embryonic kidney 293 (HEK293)
cells with Arc and increasing amounts of Triad3A cDNA, immu-
noblot analysis indicated a progressive loss of Arc protein with
increased Triad3A (Figure 2A). In addition, coexpression of
myc-Arc with hemagglutinin (HA)-ubiquitin (HA-Ub) revealed
robust Arc ubiquitination in the presence of Triad3A (Figure 2B).
In contrast to wild-type Triad3A, expression of mutant Triad3A
lacking the second RING domain (Triad3A-DR2) did not promote
Arc ubiquitination (Figure 2B). The predominant Triad3 isoformst forebrain were immunoblotted for Triad3A, PSD-95, and synapsin I. For each
membrane (SPM) and S3 fractions, or 3 mg of PSD fractions (PSDI, PSDII, and
h S3 and PSDII fractions. WB, whole brain.
rc were expressed in HEK293 cells and immunoprecipitated (IP) with antibodies
ting (IB) with anti-Flag (left) or anti-myc antibodies (right). Asterisks represent the
IgG) heavy chain band. Molecular mass markers are shown on the left.
ollowing seizure induction with pilocarpine, lysates from mouse hippocampus
oteins were subjected to immunoblot (IB) analysis using an anti-Arc antibody.
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Figure 2. Triad3A Ubiquitinates Arc
(A) HEK293T cells expressing myc-Arc were transfected with increasing amounts of Flag-Triad3A cDNA. Cell lysates were resolved by SDS-PAGE and
immunoblotted with indicated antibodies.
(B) Lysates from HEK293 cells expressing myc-Arc and HA-ubiquitin (Ub), along with wild-type Flag-Triad3A or inactive FLAG-Triad3A-DR2 lacking the RING2
domain, were subjected to immunoprecipitation (IP) with an anti-myc antibody followed by immunoblot (IB) analysis using an anti-HA antibody. Ubiquitinated Arc
appears as a high molecular mass smear. Molecular mass markers in kilodaltons are shown on the left. Ubn represents polyubiquitin conjugates.
(C) Examination of Arc ubiquitination with multiple ubiquitin E3 ligases. Lysates from HEK293 cells expressing myc-Arc and HA-ubiquitin (Ub) along with various
ubiquitin E3 ligases were subjected to immunoprecipitation (IP) with an anti-myc antibody followed by immunoblot (IB) analysis using an anti-HA antibody to
detect ubiquitinated Arc. Asterisks in the bottom panel identify input control bands. Molecular mass markers in kilodaltons are shown on the left.
(D) Comparison of coimmunoprecipitation of Arc with Ube3a and Triad3A. HEK293T cells were transfected with HA-Ube3a, Flag-Triad3A, or myc-Arc. Cell
extracts were immunoprecipitated with an anti-HA or anti-Flag antibody. Immunoprecipitates (IP) were separated by SDS-PAGE and immunoblotted (IB) with
anti-myc, anti-HA, or anti-FLAG antibodies. Arc robustly coprecipitated with Flag-Triad3A.
(E and F) HA-Ube3a and Flag-Triad3A were expressed in 293T cells and immunopurified from cell extracts. Immunopurified E3s were added to an in vitro
ubiquitination reaction containing 0.15 mg of GST-tagged full-length Arc (1–396) (E) or a GST-tagged truncated Arc (132–396) fragment (F), 0.1 mg E1, 0.5 mg of
(legend continued on next page)
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Triad3A Ubiquitinates Arcin the brain are Triad3A, -3D, and -3E (Chuang and Ulevitch,
2004), splice variants that differ only in their N-terminal domains
(Figure S2A, top panel). Although variably spliced, Triad3C,
Triad3D, and Triad3E encode for the same protein (Figure S2A,
top panel). Both Triad3A and Triad3B, but not Triad3C, promoted
Arc ubiquitination (Figure S2A). Whereas Triad3A and Triad3B
strongly induced Arc ubiquitination, the related RING-IBR-
RING E3 ligase parkin did not (Figure S2A). Moreover, we did
not detect ubiquitination of Arc upon coexpression with other
known E3s that are expressed in the brain including Ube3a,
Smurf1, Smurf2, and NEDD4-1 (Figure 2C).
Previously, Ube3a was identified as a ubiquitin E3 ligase for
Arc (Greer et al., 2010). In contrast to Triad3A, we were unable
to detect Ube3a-dependent Arc ubiquitination (Figure 2C),
similar to recent findings (Ku¨hnle et al., 2013). However, expres-
sion of wild-type Ube3a, but not the catalytically inactive
mutant Ube3a (C883A), reduced Arc protein levels (Figure S2B),
as previously reported (Greer et al., 2010). Compared to
Triad3A, which efficiently coimmunoprecipitated with Arc, we
were unable to detect an interaction between Ube3a and Arc
in HEK293 cells (Figure 2D). However, we did observe a weak
interaction between endogenous Ube3a and Arc in hippo-
campal neurons (Figure S2C). Knockdown of Triad3A in hippo-
campal neurons did not increase the interaction between Arc
and Ube3a, suggesting that Triad3A does not compete with
Ube3a for Arc binding (Figure S2C). Using in vitro ubiquitination
assays, we found that Triad3A efficiently ubiquitinated full-
length recombinant Arc, whereas Ube3a did not (Figure 2E;
compare lanes 4 and 8). We then purified a fragment of Arc
(amino acids 132–396) that lacks the N-terminal coiled coil
and endophilin-3 binding domains and was previously demon-
strated to be a Ube3a substrate in vitro (Greer et al., 2010).
Both Triad3A and Ube3a could ubiquitinate this Arc fragment
(Figure 2F). However, unlike the high-molecular-mass poly-
ubiquitinated smear observed with full-length Arc (Figure 2E),
we observed a small 7 kDa shift in molecular weight to an
apparent single species (Figure 2F). Finally, cortical neurons
from Ube3am/p+ mice were examined for Arc K48-linked
polyubiquitination using a K48 linkage-specific antibody that
recognizes the predominant ubiquitin chain associated with
proteasome-dependent degradation (Newton et al., 2008).
Immunoprecipitation and immunoblot analysis revealed an
increase in Arc protein levels in Ube3am/p+ cortical neurons
compared to wild-type neurons as previously described (Greer
et al., 2010) (Figure 2G). However, we also detected an increase
in K48-linked Arc ubiquitin conjugates, indicating that Arc is
still capable of being ubiquitinated in the absence of Ube3a
(Figure 2G).UbcH7, and 10 mg of recombinant ubiquitin. Samples were incubated for 2 hr at
anti-Arc antibody to detect ubiquitin conjugates or anti-HA and anti-Flag antibodie
are both active as they are capable of self-ubiquitination. Whereas high molecula
single apparent monoubiquitinated species of Arc (132–396) was observedwith b
are shown on the left.
(G) Arc levels are increased and Arc ubiquitin conjugates are present in neurons la
2 mM TTX for 24 hr to normalize activity levels prior to solubilization. Cell lysates w
using anti-ubiquitin (Ub), anti-K48-linked ubiquitin, or anti-Arc antibodies. Ubiquiti
kilodaltons are shown on the left.Triad3A Ubiquitinates Arc at Lysines 268 and 269
To determine which region of Arc serves as the target for
Triad3A-dependent ubiquitination, we coexpressed Flag-
Triad3A and HA-Ub with various Arc deletion mutants lacking
the coiled-coil domain (DCC), endophilin-3 binding domain
(DEB), and spectrin-repeat homology domains (DSRH) (Fig-
ure 3A). Deletion of the SRH domain of Arc abolished ubiquitina-
tion by Triad3A (Figure 3A). To identify the lysine residue(s) of Arc
that is (or are) ubiquitinated by Triad3A, we performed mass
spectrometry on purified Arc following in vitro ubiquitination
with Triad3A. His-tagged Arc was purified from insect cells,
and Flag-tagged Triad3A was isolated from HEK293 cells (Fig-
ure S3A). When screening various E2 proteins, we found that
both UbcH5 and UbcH7 efficiently supported Triad3A-depen-
dent ubiquitination of Arc in vitro (Figure S3B). We then per-
formed in vitro Arc ubiquitination assays in the presence of E1,
E2 (UbcH7), recombinant His-Arc, Flag-Triad3A, and purified
ubiquitin lacking internal lysines (Figure S3C). Arc was purified
under denaturing conditions, resolved by SDS-PAGE, stained
with Coomassie blue (Figure S3C), band isolated, and subjected
to in-gel trypsin digestion for liquid chromatography and tandem
mass spectrometry analysis. Our analysis identified four lysines
(K55, K136, K268, and K293) as sites of ubiquitination (Fig-
ure 3B). Of these sites, lysines 55 and 268 were ubiquitinated
by Triad3A in more than one experiment (Figure 3B).
We next mutated candidate lysine residues and coexpressed
Arc mutants with Triad3A in HEK293 cells. Single-site mutation
of each of the four lysines (K55A, K136A, K268A, and K293A)
had no effect on Triad3A-induced ubiquitination (Figure 3C).
However, we noted the presence of a conserved lysine residue
adjacent to K268 that was not identified in the mass spectro-
metric analysis. Indeed, whereas Arc-K268A and Arc-K269A
were each robustly ubiquitinated by Triad3A, mutation of
both residues to alanine almost completely abolished Triad3A-
induced ubiquitination (Figure 3C). Similar results were obtained
with a lysine-to-arginine double mutant Arc-K268R/K269R (data
not shown). We then coexpressedwild-type Arc (Arc-WT) or Arc-
K268R/K269R (hereinafter referred to as Arc-KR) in HEK293 cells
and performed 35S-Cys/Met metabolic labeling and pulse-chase
analysis. Introduction of K268R and K269R mutations signifi-
cantly slowed Arc degradation (Figures 3D and 3E). Since Arc
decay was still observed in the Arc-KR mutant, we mutated all
lysines of Arc (K55R/K136R/K268R/K269R/K293R) that were
identified as being ubiquitinated (referred to as Arc-ALL) and
monitored decay of protein levels following cyclohexamide treat-
ment (Figure S3D). As expected, Arc-KR levels decayed slower
than Arc-WT (Figure S3D). However, we did not observe a differ-
ence in decay between Arc-KR and Arc-ALL, suggesting that30C, resolved by SDS-PAGE, and subjected to immunoblot (IB) analysis with
s to detect immunopurified E3s. Immunopurified HA-Ube3a and FLAG-Triad3A
r mass ubiquitin conjugates of Arc (1–396) were observed with Triad3A in (E), a
oth Triad3A and Ube3a in (F) (mono-Ub). Molecular mass markers in kilodaltons
cking Ube3a. Cortical neurons DIV14 from Ube3am/p+mice were treated with
ere immunoprecipitated (IP) with an anti-Arc antibody, and immunoblotted (IB)
nated Arc appears as a highmolecular mass smear. Molecular mass markers in
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Figure 3. Triad3A Ubiquitinates Arc at Lysines 268 and 269
(A) The spectrin-repeat homology (SRH) domain of Arc is required for Triad3A-dependent ubiquitination. Lysates fromHEK293 cells expressingmyc-Arc mutants
and HA-ubiquitin (Ub) along with wild-type Flag-Triad3A were subjected to immunoprecipitation (IP) with an anti-myc antibody followed by immunoblot (IB)
analysis using an anti-HA antibody. Ubiquitinated Arc appears as a highmolecularmass smear. Deletion of the SRH domain abolishes Arc ubiquitination. h.c., IgG
heavy chain. Top panel shows Arc deletion mutants. CC, coiled-coil domain; EB, endophilin-3 binding domain.
(B) Ubiquitin-conjugated lysine residues following in vitro ubiquitination of Arc by Triad3A. Four ubiquitination sites were identified in three independent
experiments by MS. Top, table of isolated Arc tryptic peptides containing ubiquitinated lysines (red). Bottom, schematic of Arc showing ubiquitinated lysines
(K55, K136, K268, and K293) and the adjacent lysine K269. Protein domain labels are as in (A).
(C) Triad3A-mediated ubiquitination requires lysines 268 and 269 of Arc. HEK293 cells expressing FLAG-Triad3A andHA-ubiquitin (Ub) alongwith either wild-type
(wt) myc-Arc or myc-Arc mutants were subjected to immunoprecipitation (IP) with an anti-myc antibody, followed by immunoblot (IB) analysis with an anti-HA
antibody to detect ubiquitinated Arc. Arc ubiquitination by Triad3A was nearly abolished bymutation of both K268 and K269. Molecular mass markers are shown
in kilodaltons.
(D) Arc protein stability increases on mutation of both K268 and K269 residues. Examples of 35S-Cys/Met pulse-chase data of myc-Arc (WT, left) and myc-Arc
K268R/K269R (KR, right) coexpressed with Triad3A in HEK cells are shown.
(E) Quantitative analysis of 35S-Cys/Met pulse-chase data. Data represent means ± SEM of the percent remaining labeled Arc following various times of
chase. *p < 0.05, n = 3.
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Triad3A Ubiquitinates ArcK268 andK269 are the primary sites of Arc ubiquitination (Figures
S3D and S3E). The continued degradation of Arc-KR and Arc-
ALL could be due to the presence of a strong predicted PEST
motif that is located at the C terminus of Arc (Rao et al., 2006).1304 Neuron 82, 1299–1316, June 18, 2014 ª2014 Elsevier Inc.Triad3A Regulates Arc Turnover in Neurons
To examine the role of endogenous Triad3A in regulating Arc sta-
bility, we utilized RNA interference (RNAi) for loss-of-function
analysis.We identified two short hairpin RNA (shRNA) sequences
Neuron
Triad3A Ubiquitinates Arcthat efficiently reduced Triad3A protein levels (Figure S4).
Expression of these shRNAs in hippocampal neurons decreased
Triad3A immunostaining by approximately 75% (Figures S4C
and S4D). Lentiviral transduction of Triad3 shRNA resulted in
a significant reduction of endogenous Triad3A relative to a
scrambled shRNA control (Figure S4E). We next examined Arc
expression elicited by 4AP/Bic in hippocampal neurons trans-
duced with Triad3 shRNA (Figure 4A) and observed an increase
in Arc accumulation compared to scrambled control (2.6 ± 0.4
fold increase, p < 0.05; Figures 4A and 4B). Along with an
increase in Arc, Triad3A levels were slightly decreased with
4AP/Bic, potentially due to Triad3A autoubiquitination. Following
induction by 4AP/Bic, degradation of 35S-labeled Arc was signif-
icantly slower in neurons expressing Triad3 shRNA, compared
to neurons expressing a scrambled control shRNA (Figures 4C
and 4D). Immunoblot analysis of total Arc from radiolabeled
lysates confirmed the persistence of Arc following 4AP/Bic in
neurons lacking Triad3A (Figure 4C).
In further experiments, we monitored endogenous Arc in hip-
pocampal neurons upon Triad3A overexpression or knockdown
in the presence or absence of elevated synaptic activity (Fig-
ure 4E). As expected, 4AP/Bic treatment increased Arc levels
within 4 hr (Figures 4E and 4F). In neurons with reduced levels
of Triad3A, activity-induced Arc levels were increased by
2-fold (Figures 4E and 4F). Coexpression of RNAi-resistant
Triad3A reversed the increase in Arc (Figure 4F). In addition,
overexpression of Triad3A blocked the activity-induced increase
in Arc, resulting in Arc levels that were similar to those observed
without activity (Figures 4E and 4F). Furthermore, knockdown
of Triad3A abolished 4AP/Bic-induced Arc ubiquitination in
cortical neurons (Figure 4G).
Triad3A Associates with Arc at Sites of Endocytosis
Recent studies have found that Arc facilitates the endocytosis of
AMPA receptors through interactions with dynamin-2 and endo-
philin-3 (Chowdhury et al., 2006; Rial Verde et al., 2006; Shep-
herd et al., 2006). We investigated whether Triad3A-mediated
Arc ubiquitination affects the kinetics and localization of Arc
within the endocytic pathway. In COS7 cells, green fluorescent
protein (GFP)-tagged Triad3A puncta colocalized with clathrin-
DsRed, which marks sites of endocytosis (Figures 5A and 5B).
Furthermore, mCherry-Triad3A puncta colocalized with the cla-
thrin endocytic adaptor, GFP-Eps15 (Figure 5A, bottom panel),
and GFP-dynamin 2 (data not shown). We next coexpressed
GFP-Triad3A with DsRed-tagged clathrin light chain in COS7
cells and examined surface colocalization using total internal
reflection fluorescence microscopy (TIRFM) (Merrifield et al.,
2005). TIRFM revealed punctate spots of GFP-Triad3A that
colocalized with clathrin (Figure 5C; Figures S5A and S5B). We
also observed colocalization of Arc and Triad3A in COS7 cells,
albeit to a lesser degree (Figures 5B and S5C).
Using live-cell TIRFM imaging, compared to Arc, Triad3A
persisted for longer periods at membrane puncta (Triad3A,
27.1 ± 2.3 s; Arc-WT, 10.2 ± 1.0 s; Figures 5C–5F, 5H, and
S5D; Movies S1 and S2). The transient association of Arc with
clathrin-coated pits (CCPs) is similar to the reported dynamics
of its interacting partners, endophilin-3 and dynamin-2 (Perrais
and Merrifield, 2005). Mutations of the K268 and K269 ubiquiti-nation sites of Arc (Arc-KR) resulted in a more stable association
at the membrane (17.3 ± 1.6 s) (Figures 5E, 5G, 5H and S5E;
Movie S3). It is intriguing that Arc-KR puncta were near but
seldom directly overlapped with CCPs, suggesting that Triad3A-
dependent ubiquitination might couple Arc to sites of endo-
cytosis or prevent persistent association of Arc with endocytic
intermediates following clathrin uncoating (Chowdhury et al.,
2006; Wu et al., 2011). In neurons, GFP-Triad3A colocalized
with clathrin-DsRed in dendritic shafts and spines of hippocam-
pal neurons (Figure 6A) but not with the postsynaptic density
marker Homer-DsRed (Figure 6B). To test whether Triad3A local-
izes to the endocytic zone (EZ) within spines, we coexpressed
GFP and clathrin-DsRed in hippocampal neurons and immu-
nostained for endogenous Triad3A (Figure 6C). Endogenous
Triad3A in dendritic spines tightly overlapped with clathrin-
DsRed within a subdomain of the spine (Figure 6C). Consistent
with the lateral localization of the EZ, Triad3A staining was
localized adjacent to the PSD (Figure 6D). The percentage of
PSDs containing adjacent Triad3A puncta was 55%± 5%,which
is slightly lower than previous findings for EZ-positive spines
(Blanpied et al., 2002; Lu et al., 2007). Furthermore, Triad3A
did not tightly overlap with syntaxin-4, a marker of exocytic
domains within dendritic spines (Figure S5F) (Kennedy et al.,
2010). To examine the synaptic distribution of Triad3A in vivo,
we performed immunogold electron microscopy (EM) of rat
CA1 hippocampus. Triad3A immunogold labeling was present
near the membrane and on vesicle-like structures in both
presynaptic terminals and postsynaptic spines (Figure 6E),
similar to our biochemical observations (Figure 1E). Quantitative
analysis indicated that a significant fraction (>30%) of gold
particles were positioned along the plasma membrane near
the PSD (Figure 6E, black arrows), with a 2-fold decrease in
Triad3A labeling at spine membrane locations further away
from the PSD (Figure 6F).
Triad3A Is Required for Arc-Dependent Synaptic
Plasticity
Postsynaptic endocytosis regulates synaptic AMPA receptor
levels (Lu¨scher et al., 1999; Newpher and Ehlers, 2008), and
Arc is known to facilitate AMPA receptor endocytosis (Chowd-
hury et al., 2006; Rial Verde et al., 2006; Waung et al., 2008).
Regulation of Arc levels results in reciprocal changes in the
expression of surface AMPA receptors that can occur under
baseline conditions and is most robust on chronic changes in
synaptic activity (Be´ı¨que et al., 2011; Craig et al., 2012; Gao
et al., 2010; Shepherd et al., 2006; Waung et al., 2008). We
reasoned that a reduction of Triad3A should phenocopy Arc
overexpression, whereas overexpression of Triad3A should
mimic effects of Arc knockdown or knockout (KO). Consistent
with this notion, shRNA knockdown of Triad3A led to increased
endocytosis of the AMPA receptor subunit, GluA1 (Figures 6G
and 6I). Conversely, overexpression of Triad3A decreased endo-
cytosis of GluA1 AMPA receptors (Figures 6G and 6I), similar to
that observed in Arc KO neurons (Chowdhury et al., 2006).
Notably, shRNA knockdown of Triad3A decreased GluA1
receptor levels at the cell surface (Figures S6A and S6B), and
this effect could be rescued by coexpressing an RNAi-resistant
form of Triad3A (Figure S6B). Conversely, overexpression ofNeuron 82, 1299–1316, June 18, 2014 ª2014 Elsevier Inc. 1305
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Figure 4. Triad3A Regulates Arc Stability and Turnover
(A) Enhanced Arc induction upon depletion of Triad3A in hippocampal neurons. Hippocampal neurons were transduced with control or Triad3 lentiviral shRNAs
and treated with either TTX (2 mM) or 4AP/Bic. Cell lysates were resolved by SDS-PAGE and immunoblotted with Arc- or Triad3A-specific antibodies. Note that
Triad3A knockdown results in higher Arc levels after 4AP/Bic induction.
(B) Means ± SEM of Arc levels under the indicated conditions displayed as a fold change relative to the Scr control. *p < 0.05, n = 3.
(C) Loss of Triad3A increases Arc half-life in neurons. Hippocampal neurons were incubated with control lentiviral shRNA or Triad3-shRNA and treated with either
TTX (2 mM) or 4AP/Bic. Neurons were then incubated in 35S-Cys/Met for metabolic labeling and pulse-chase analysis, as shown in the upper panel. Immunoblots
of radiolabeled extracts using anti-Arc, anti-Triad3A, and anti-tubulin antibodies are shown in the lower blots. Note the reduced turnover of Arc (35S-Arc), as well
as the increased remaining total Arc in neurons lacking Triad3A.
(D) Quantification of Arc half-life 3 hr after 4AP/Bic treatment displayed as a fold change relative to Scr control. Data represent means ± SEM. *p < 0.05, n = 3.
(E) Immunostaining for Arc upon Triad3A overexpression or downregulation. DIV14 hippocampal neurons were transfected with cDNA encoding GFP along with
either myc-Triad3A or Triad3-shRNA for 72 hr. Cells were treated with TTX or 4AP/Bic for 4 hr prior to fixation and immunostaining for Arc. Arrows indicate
reduced Arc levels in a Triad3A overexpressing neurons. Arrowheads indicate elevated Arc in neurons expressing Triad3 shRNA. Scale bars, 25 mm.
(F) Data represent means ± SEMof Arc staining in neurons expressingGFP-Triad3A, Triad3-shRNA, or shRNA-resistant Triad3A (Triad3A*) from (E). AFU, arbitrary
fluorescence units. *p < 0.01, n = 6–22.
(G) Triad3A is required for activity-induced Arc ubiquitination in neurons. Cortical neurons transduced with Scr or Triad3 (T3) shRNA lentivirus and incubated with
TTX or 4AP/Bic. Arc was immunoprecipitated from cell extracts under denaturing conditions. Immunoprecipitates were resolved by SDS-PAGE and probed with
an anti-K48 linkage-specific ubiquitin antibody or anti-Arc antibody. 4AP/Bic induced Arc polyubiquitination (lane 3) that was prevented by Triad3-shRNA (lane 4).
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Triad3A Ubiquitinates ArcTriad3A produced an increase in surface AMPA receptors
(Figures S6A and S6B), similar to that observed in Arc KO neu-
rons. Thus, Triad3A and Arc exert reciprocal effects on AMPA
receptor surface trafficking. To determine if Triad3A functions
in the same endocytic pathway as Arc tomediate GluA1 endocy-
tosis, we coexpressed Endophilin 3 (Endo3-WT) and a dominant
negative version of Endophilin 3 (172–347) (Endo3-CT) that
interacts with Arc and interferes with Arc-induced AMPAR endo-
cytosis (Chowdhury et al., 2006). As described earlier (Figures
6G and 6I), expression of Triad3 shRNA increased GluA1 endo-
cytosis compared to scrambled shRNA control (Scr) (Figures
S6C and S6D). However, coexpression of Triad3-shRNA with
Endo3-CT prevented this increase in GluA1 endocytosis medi-
ated by Triad3-shRNA (Figures S6C and S6D). Triad3A-depen-
dent Arc ubiquitination occurs on K268 and K269. To examine
if ubiquitination of Arc by Triad3A mediates GluA1 endocytosis,
we coexpressed Arc-WT or Arc-KR with Triad3A. Overexpres-
sion of Triad3A reduced GluA1 endocytosis, and this was not
affected by coexpression of Arc-WT (Figures 6H and 6J).
However, expression of Arc-KR stimulated GluA1 endocytosis,
despite coexpression of Triad3A (Figures 6H and 6J), indicating
that Triad3A negatively regulates GluA1 endocytosis by ubiquiti-
nation of Arc at K268/269.
Arc is required for multiple forms of activity-dependent synap-
tic plasticity, including homeostatic scaling, hippocampal LTP,
and protein synthesis-dependent LTD (Gao et al., 2010; Guzow-
ski et al., 2000; Jakkamsetti et al., 2013; Rial Verde et al., 2006;
Shepherd and Bear, 2011; Shepherd et al., 2006; Waung et al.,
2008). In hippocampal neurons, overexpression of Triad3A
mimicked and occluded TTX-induced upregulation asmeasured
by surface expression of synaptic GluA1 (Figures 7A and 7B). In
contrast, Triad3A knockdown blocked the scaling effects of TTX
(Figures 7A and 7C). To confirm our findings, we tested the effect
of Triad3A on miniature excitatory postsynaptic currents
(mEPSCs) following chronic activity manipulations. Whereas
Triad3A overexpression mimicked and occluded the increase
of mEPSC amplitudes normally induced by TTX treatment
(48 hr, 1 mM), Triad3A knockdown prevented any TTX-induced
increase in mEPSC amplitudes (Figures 7D–7H). Given the
inverse relationship between Arc levels and its ubiquitinating
enzyme Triad3A, these data support a model whereby negative
regulation of Arc by Triad3A mediates TTX-induced upscaling
(Shepherd et al., 2006).
Arc synthesis is required for LTD elicited by the mGluR1/5
agonist 3,5-dihydroxyphenylglycine (DHPG) in CA1 hippocam-
pus, a form of synaptic plasticity termed mGluR-LTD (Waung
et al., 2008). We reasoned that, by targeting Arc for degradation,
Triad3A might act to dampen or limit mGluR-LTD. In control
neurons expressing GFP, bath application of DHPG (100 mM,
10min) led to a robust depression of mEPSC amplitudes and fre-
quency (Figures 8A and 8E). Overexpression of GFP-Triad3A
prevented this mGluR-induced synaptic depression (Figures
8B and 8E; percent reduction: GFP, 22% ± 1%; GFP-Triad3A,
2% ± 3%), consistent with a reduction in activity-induced Arc
(Figures 4E and 4F). We then knocked down Triad3A by express-
ing Triad3-shRNA in hippocampal neurons (Figure 8D). In control
neurons expressing a scrambled shRNA, DHPG application
produced a significant depression of mEPSC amplitude andfrequency (Figures 8C and 8F). Notably, in neurons expressing
Triad3-shRNA, we observed a larger decrease in mGluR-depen-
dent mEPSC amplitude, with a nearly 2-fold greater reduction in
mEPSC amplitudes relative to Scr control (Figures 8C, 8D, and
8F; percent reduction: Scr, 12% ± 3%; Triad3-shRNA, 21% ±
2%), supporting the hypothesis that control of Arc levels by
Triad3A determines the degree or extent of synaptic depression
induced by mGluR activation.
DISCUSSION
In the present study, we have identified Triad3A/RNF216 as an
E3 ubiquitin ligase targeting Arc—an activity-regulated gene
product that regulates AMPA receptor endocytosis and synaptic
plasticity. We have demonstrated that Triad3A is present at
CCPs, including endocytic zones of dendritic spines. By limiting
Arc protein levels induced by synaptic activity, Triad3A regulates
Arc-dependent forms of synaptic plasticity. Our findings support
a model, in which the upregulation and recruitment of Arc to
the endocytic machinery is coupled to its ubiquitination and
degradation by Triad3A.
An Ubiquitin-Dependent Brake on Arc-Induced
Plasticity
Many formsof synapticplasticity areexpressedby the insertionor
removal of AMPA receptors from the postsynaptic membrane
(Kessels and Malinow, 2009; Malenka and Bear, 2004; Newpher
and Ehlers, 2008). In response to learning-related synaptic
activity and protein-synthesis-dependent LTD, Arc is rapidly
induced (Guzowski et al., 1999; Lu¨scher and Huber, 2010; Lyford
et al., 1995; Steward et al., 1998) and facilitates endocytosis of
synaptic AMPA receptors (Waung et al., 2008). Arc-mediated
endocytosis of AMPA receptors dampens excitatory synaptic
transmission, and this compensatory decrease in synaptic
strength mediates homeostatic plasticity (Chowdhury et al.,
2006; Rial Verde et al., 2006; Shepherd et al., 2006). Here, we
have shown that Arc half-life and, hence, Arc levels are
determined by ubiquitin-dependent degradation mediated by
Triad3A. Triad3A binds to Arc and ubiquitinates Arc at lysines
268 and 269. Furthermore, Triad3A is required for homeostatic
synaptic upscaling and mGluR-induced synaptic depression.
AlthoughTriad3A is required for TTX-induced upscaling of synap-
tic strength, manipulations of Triad3A did not significantly
influencedownscalingofAMPA receptors followingBic treatment
(data not shown). These findings are consistent with those of
Shepherd et al., who found a larger effect of Arc on TTX-induced
upscaling, whereas Arc KOneuronswere still capable of synaptic
depression induced by Bic (Shepherd et al., 2006). Thus, Triad3A
and Arc share similar properties for synaptic scaling. In addition,
we have shown that Triad3A exerts tonic negative regulation of
mGluR-induced synaptic depression, consistent with previous
work demonstrating that Arc synthesis is required formGluR-LTD
(Waung et al., 2008) and further supporting Triad3A’s role in
mediating Arc. By controlling Arc levels via ubiquitination and
UPS-dependent degradation, Triad3A limits AMPA receptor
endocytosis and associated synaptic depression.
In addition to regulating rapid forms of synaptic plasticity,
loss of Arc or deletion of the endophilin binding domain ofNeuron 82, 1299–1316, June 18, 2014 ª2014 Elsevier Inc. 1307
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Triad3A Ubiquitinates ArcArc both prevent forms of homeostatic synaptic plasticity (Be´ı¨-
que et al., 2011; Gao et al., 2010; Shepherd et al., 2006) that
globally scale AMPA receptor-dependent synaptic currents
(Turrigiano, 2008). Such slow forms of homeostatic plasticity
are known to require ubiquitin-dependent degradation and
remodeling of the PSD. The translation of Arc mRNA is rapidly
induced by activation of group I mGluRs, and this synthesis of
Arc is coupled to depression of synaptic strength in a manner
regulated by the fragile X mental retardation protein (FMRP)
(Niere et al., 2012; Park et al., 2008; Waung et al., 2008). We
found that disruption of the dynamic cycle of Arc induction
and subsequent degradation by knockdown of Triad3A pre-
vents mGluR-dependent synaptic depression. Given the role
of Arc in executing both rapid and more chronic forms of
synaptic plasticity, an attractive model is that Arc protein levels
are under continuous online regulation via regulated synthesis
and degradation, the latter of which is controlled by Triad3A.
These findings are supported by recent work, which demon-
strates that Arc levels dictate the ability of a cell to elicit
mGluR-LTD (Jakkamsetti et al., 2013). One prediction of this
model is that alteration of Triad3A can trigger both immediate
and longer term effects on synaptic strength that depend on
ongoing synaptic activity, patterns of receptor activation, and
homeostatic compensation. Our findings strongly suggest
that Triad3A couples protein synthesis to protein turnover by
targeting Arc for ubiquitin-dependent degradation at excitatory
synapses.
Triad3A as a Ubiquitin Ligase in the Endocytic Pathway
Arc interacts with dynamin-2 and endophilin-3, and this interac-
tion is necessary for Arc-mediated endocytosis of AMPA recep-
tors (Bramham et al., 2008; Chowdhury et al., 2006). When Arc is
expressed in HeLa cells, it localizes to both the cytoplasm and
nucleus with partial enrichment at the plasma membrane
(Chowdhury et al., 2006). This localization pattern is altered
upon coexpression with endophilin and dynamin, which results
in a redistribution of Arc to endosomal structures (Chowdhury
et al., 2006). Using TIRFM, we found that a pool of Arc localizes
to CCPs in COS7 cells. This finding, along with an increased
surface lifetime of Arc-KR, suggests that, following activity-
induced synthesis, Arc is recruited to the cell surface by molec-
ular interactions with endophilin-3 and dynamin-2, where it
encounters Triad3A residing at CCPs for subsequent ubiquiti-
nation and UPS-mediated degradation. Although our findings
support a temporal relationship between Arc synthesis, coated
pit association, and Triad3A-mediated ubiquitination, it will be
important for future studies to elucidate the precise timing andFigure 5. Ubiquitination by Clathrin-Localized Triad3A Regulates Arc D
(A) Confocal image of GFP-Triad3A and clathrin-DsRed (top panels) or mCherry-T
localized to clathrin-coated pits (yellow). Scale bar, 5 mm.
(B) TIRFM data representing means ± SEM of the percent colocalization between
bar indicates the percentage of Triad3A puncta (T3A) that colocalize with clathrin
(C) Time-lapse images demonstrating recruitment dynamics of GFP-Triad3A to c
(D) Time-lapse images demonstrating recruitment dynamics of YFP-Arc to clathr
(E) Time-lapse images demonstrating persistent association of YFP-ArcKR at or
(F) Cumulative probability plot of YFP-Arc and GFP-Triad3A lifetimes at the mem
(G) Cumulative probability plot of wild-type Arc and ArcKR lifetimes at the memb
(H) Mean lifetimes of GFP-Triad3A (T3A), YFP-Arc, and YFP-ArcKR puncta at thekinetics of Triad3A-mediated Arc ubiquitination before, during,
and after a period of facilitated endocytosis.
Similar to other UPS targets, the addition and removal of ubiq-
uitin chains on Arc likely reflect the competing activity of other
ubiquitin ligases and deubiquitinating enzymes, as well as other
ubiquitin-like modifications such as SUMOylation (Craig et al.,
2012). Moreover, ubiquitination of Arc by Triad3A at CCPs could
facilitate interactions with other endocytic proteins such as
Eps15, Eps15R, and epsin that normally localize to CCPs and
contain ubiquitin-binding motifs (Di Fiore et al., 2003). We
observed a large fraction of Arc events at the cell surface that
did not colocalize with CCPs but did colocalize with Triad3A,
suggesting that Arc may also function in dynamin-dependent
but clathrin-independent pathways to regulate endocytosis
(Hansen and Nichols, 2009). Overall, the Triad3A-Arc pathway
defined here reveals a mechanistic link between the UPS,
AMPA receptor endocytosis, and activity-dependent plasticity.
Beyond the nervous system, such a mechanism may provide a
general paradigm for the transient modification of endocytosis
in diverse tissues.
Regulating the Stability of Arc
In a recent study, the HECT domain E3 ligase Ube3a, whose
maternal copy loss causes Angelman syndrome (Kishino
et al., 1997), was found to be a direct modulator of Arc (Greer
et al., 2010). We were unable to detect Arc ubiquitination by
Ube3a in HEK293 cells, even though we found that Ube3a
overexpression reduced Arc protein levels in the same system
as reported (Greer et al., 2010). Furthermore, we failed to
detect Ube3a-dependent polyubiquitination of full-length
Arc but could detect Ube3a-dependent monoubiquitination
on a recombinant C-terminal Arc fragment (132–396) as re-
ported (Greer et al., 2010). Finally, although we could detect
a weak interaction between Arc and Ube3a in neurons, we
were unable to detect a loss of Arc ubiquitination in Ube3a
null neurons. Our findings are consistent with a recent study
showing that Ube3a does not promote ubiquitination of Arc
(Ku¨hnle et al., 2013). It is intriguing that we found that the
same two lysine residues on Arc (K268 and K269) reported to
be ubiquitinated by Ube3a (Greer et al., 2010) are direct
acceptor sites for ubiquitination by Triad3A. Ube3a may regu-
late Arc degradation following prolonged changes in synaptic
activity, whereas Triad3A may be involved in the steady-state
turnover of Arc under basal synaptic transmission and on more
immediate increases or decreases in synaptic drive. The exact
molecular interplay between Arc, Triad3A, and Ube3a remains
to be elucidated.ynamics
riad3A and GFP-Eps15 (bottom panels) in COS7 cells. Arrows indicate Triad3A
the two indicated proteins at presumptive endocytic pits. For example, the first
(Clath.).
lathrin-DsRed puncta.
in-DsRed puncta.
near clathrin-DsRed puncta.
brane as measured by TIRFM.
rane as measured by TIRFM.
cell membrane ± SEM. *p < 0.001.
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Triad3A Ubiquitinates ArcIt is interesting that, as with Ube3a, there may be a link be-
tween Triad3A and neurodevelopmental disorders. A recent
report described an autistic patient carrying a t(7;16)(22.1;
p11.2) reciprocal translocation that results in a highly selective
30-fold increase in the expression of the human Triad3 ortholog
RNF216 (also called Q6NUR6, U7I1, UBCE7IP1, and MMD2) at
chromosome 7p22.1 (Bayou et al., 2010). The RNF216 gene is
one of the genes deleted in a patient with severe colorectal can-
cer who also exhibits intellectual impairment, but lacks a brain
tumor (Will et al., 2007). Moreover, mutations and disruptions
in the Triad3/RNF216 gene have recently been described in pa-
tients with Gordon Holmes syndrome characterized by ataxia,
dementia, and hypogonadotropism accompanied by neuronal
loss and intranuclear inclusions in the cerebellum and hippo-
campus (Margolin et al., 2013). These findings suggest that
increasing or decreasing levels of Triad3A could contribute to
human intellectual disorders, potentially via modulation of Arc.
More broadly, local regulation of Arc by Triad3A may provide a
general paradigm for tuning the timing and duration of activity-
dependent plasticity in diverse neural circuits.
EXPERIMENTAL PROCEDURES
Detailedmethods regarding DNA constructs, cell culture, antibodies, immuno-
cytochemistry, protein purification, in vitro ubiquitin assays, EM, image
acquisition, and immunoprecipitation (IP) are included in the Supplemental
Experimental Procedures.
Immunoprecipitation
Constructs were transfected in HEK293 cells by Lipofectamine (Invitrogen).
Cell extracts were prepared 24 hr after transfection in IP buffer. For
endogenous interaction of Arc and Ube3a in neurons, Arc protein was immu-
noprecipitated with Gamma Bind G-Sepharose beads conjugated with an
anti-Arc antibody (Santa Cruz, C-7). For details, see the Supplemental Exper-
imental Procedures.
Metabolic Pulse-Chase Assays
For pulse-chase analysis, DIV14-17 cortical neurons (1.25 3 106 cells per
60 mm dish) were pretreated with 2 mM TTX for 24 hr. For metabolic labeling
with 35S-Cys/Met, cells were washed three times in Neurobasal media
(Invitrogen) lacking methionine and cysteine (Invitrogen) and incubated for
15 min at 37C in the presence of 2 mM TTX. Cells were then incubated forFigure 6. Clathrin-Localized Triad3A Controls GluA1 AMPAR Endocyto
(A) Colocalization of GFP-Triad3A and clathrin-DsRed in hippocampal neuron
Scale bars, 10 mm and 2 mm, respectively. The insets (right) show an example of
(B) GFP-Triad3A localizes lateral to the PSD. Arrows indicate adjacent puncta of G
and 2 mm, respectively.
(C) Colocalization of endogenous Triad3A with clathrin-DsRed in dendritic spine
immunostained with an anti-Triad3A antibody. Two examples are shown. Scale
(D) Hippocampal neurons at DIV19 expressing GFP and PSD95-mCh were fixed
but were primarily positioned lateral to the PSD. Two examples are shown. Scal
(E) Immunogold EM of Triad3A at asymmetric synapses in CA1 hippocampus in v
both presynaptic terminals (T) and postsynaptic spines (S). Within spines, Triad3
(F) Quantitative analysis of the tangential distribution of Triad3A labeling at the sp
abundant just lateral to the PSD. n = 69 particles.
(G) Representative images of DIV21 hippocampal neurons expressing GFP, GFP-
visualized by live-antibody feeding using an antibody directed against an N-term
(H) Representative images of DIV21 hippocampal neurons expressing GFP, GFP-
GluA1 AMPA receptors (int GluA1) were visualized by live-antibody feeding usin
Scale bars, 10 mm.
(I) Data represent means ± SEM of internalized GluA1 labeling in hippocampal n
(J) Data represent means ± SEM of internalized GluA1 labeling in hippocampal n4 hr in methionine-cysteine free media containing 0.3 mCi/ml of EXPRE35S35S
methionine/cysteine (PerkinElmer) in the presence of 2 mM TTX or 40 mM 4AP
plus 50 mM Bic to promote activity-dependent Arc protein induction. For
details, see the Supplemental Experimental Procedures.
In Vitro Ubiquitin Assays
In vitro ubiquitination of Arc was performed using 0.1 mg of recombinant ubiq-
uitin E1 (Boston Biochem), 0.5 mg recombinant ubiquitin E2 (UbcH7; Boston
Biochem), 10 mg of recombinant ubiquitin (Boston Biochem), and 0.1 mg immu-
nopurified Flag-Triad3A added to 0.25 mg of His-tagged Arc (or 0.15 mg of
glutathione S-transferase [GST]-Arc full-length or GST-Arc 132–396) in the
presence of an ATP regenerating system (10 mM creatine phosphate, 10 U
creatine kinase, 1 U inorganic pyrophosphatase, and 2 mM ATP) in 50 mM
Tris (pH 7.6) and 5 mM MgCl2 in a 120 ml reaction with 1 mg/ml aprotinin and
1 mM phenylmethylsulfonyl fluoride (PMSF). GST-Arc was purchased from
BD Pharmingen. GST-Arc (132–396) was expressed and purified as described
elsewhere (Chowdhury et al., 2006; Greer et al., 2010). The reaction was
incubated at 30C for 120 min. Reactions were terminated by boiling samples
in SDS-PAGE loading buffer, polypeptides were resolved by SDS-PAGE gel,
and immunoblot analysis was performed with an anti-His antibody to detect
ubiquitinated bands or with anti-Flag antibody to detect immunopurified
Flag-Triad3A. For additional assay information, see Supplemental Experi-
mental Procedures.
Electrophysiology
Homeostatic Scaling and Baseline mEPSC Recordings
Neurons were held at 65 mV using a MultiClamp 700B amplifier (Molecular
Devices) controlled with a computer running MultiClamp Commander and
pClamp (Molecular Devices), filtered at 2 kHz, and digitized at 40 kHz (Dig-
idata 1440A, Molecular Devices). Only cells with stable series resistance
<30 MU were included for analysis. Data were analyzed offline using Clamp-
Fit (Molecular Devices) or MiniAnalysis software (Synaptosoft). Detection
criteria for mEPSCs included amplitude greater than 8 pA and rise times
from the onset to the peak of less than 5 ms. Only recordings maintained
more than 10 min were analyzed. For details, see the Supplemental Experi-
mental Procedures.
DHPG-Induced Synaptic Depression
Recordings of mEPSCswere performed in hippocampal neurons obtained at a
holding potential of 75 mV using an Axon Multiclamp 700B amplifier (Molec-
ular Devices), filtered at 3 kHz, and digitized at 20 kHz (Digidata 1440A, Molec-
ular Devices). Data acquisition was performed using pClamp 10 (Molecular
Devices). Analysis of mEPSCs was performed using MiniAnalysis software
(SynaptoSoft). Events were manually analyzed and were accepted if they
had an amplitude >6 pA (events below this amplitude were difficult to distin-
guish from baseline noise) and a faster rise than decay. Cumulative probabilitysis
s. Arrows indicate colocalized puncta of GFP-Triad3A and clathrin-DsRed.
colocalized GFP-Triad3A and clathrin-DsRed.
FP-Triad3A (green) and the PSD-marker Homer-DsRed (red). Scale bars, 10 mm
s. Hippocampal neurons expressing GFP and clathrin-DsRed were fixed and
bars, 2 mm.
and stained for Triad3A. Triad3A puncta partially overlapped with PSD95-mCh
e bars, 2 mm.
ivo. Triad3A labeling was present at membrane sites and vesicular structures in
A labeling was at sites adjacent to the PSD (arrows). Scale bars, 200 nm.
ine membrane as a function of distance from the PSD. Triad3A labeling is most
Triad3A, or Triad3-shRNA. Internalized GluA1 AMPA receptors (int GluA1) were
inal extracellular epitope of GluA1. Scale bars, 10 mm.
Triad3A, myc-Arc (Arc-WT), and myc-Arc K268R/K269R (Arc-KR). Internalized
g an antibody directed against an N-terminal extracellular epitope of GluA1.
eurons from (G). *p < 0.05, n = 10–12.
eurons from (H). *p < 0.05, n = 7–10.
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Figure 7. Triad3A Is Required for Activity-
Induced Upscaling of Synaptic Strength
(A) Representative images of hippocampal neurons
DIV21–DIV24 expressing GFP, GFP-Triad3A, Scr
shRNA, or Triad3-shRNA treated in the presence of
1 mM TTX for 48 hr. Surface AMPA receptors
(sGluA1) were visualized by live GluA1 antibody
labeling and subsequent fixation under non-
permeabilized conditions. Scale bars, 10 mm. Con,
control.
(B and C) Quantitative analysis of surface GluA1
labeling on hippocampal neurons expressing
GFP-Triad3A (B) or Triad3-shRNA (C). Data repre-
sent means ± SEM. *p < 0.05, n = 6–23. **p < 0.005,
n = 6–23.
(D) mEPSC recordings from neurons DIV17–DIV21
expressing GFP, GFP-Triad3A, or Triad3-shRNA
treated with 1 mM TTX for 48 hr. Note the increase
in mEPSC amplitudes in GFP-expressing neurons
following TTX treatment that is prevented by
Triad3A-shRNA and occluded by Triad3A over-
expression.
(E) Cumulative mEPSC amplitude distribution sum-
marizing data fromGFP (top), GFP-Triad3A (middle),
and Triad3-shRNA-expressing cells (bottom) in
control and following TTX treatment.
(F) Cumulative mEPSC interevent interval distri-
bution summarizing data from GFP- (top), GFP-
Triad3A- (middle), and Triad3-shRNA-expressing
cells (bottom) in control and following TTX treat-
ment. Note that mEPSC frequency is not affected by
GFP-Triad3A or Triad3-shRNA.
(G) Data represent means ± SEM of mEPSC ampli-
tudes. *p < 0.05, n = 11–13.
(H) Data represent means ± SEM of mEPSC
frequencies, n = 11–13.
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Neuron
Triad3A Ubiquitinates Arccurves for mEPSC amplitude and interval were constructed using Origin
(MicroCal). Statistical significance was measured using a one-way analysis
of variance (ANOVA), with 0.05% taken as significant. For details, see the
Supplemental Experimental Procedures.
Animals
All animal procedures were performed under protocols compliant and
approved by the Institutional Animal Care and Use Committees of Duke
University, Duke-NUS, Pfizer, the University of Warwick, and the University
of North Carolina.
Statistical Analysis
Unless otherwise stated, error bars represent the SEM. Statistical analyses
applied were the post hoc Student’s t test or repeated-measures ANOVA,
with pairwise multiple comparisons where the significance criterion was
p = 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and three movies and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2014.05.016.
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(A) Representative AMPAR-dependent mEPSC traces from a neuron expressi
(i) mEPSC amplitude distributions from the same cell as in (A). Note the reduction
and there is an increase inmain peak amplitude). Inset, superimposed averagemE
mEPSC amplitude distribution summarizing data from GFP-expressing cells at ba
distribution summarizing data from the same cells as (ii). ***p < 0.0001. Data are
(B) Representative AMPAR-dependent mEPSC traces from a neuron expressing
(i) mEPSC amplitude distributions from the same cell as in (B). Note that DHPG ha
recorded at baseline and after DHPG exposure. (ii) Cumulative mEPSC amplitude
and after DHPG exposure. p = 0.073. (iii) CumulativemEPSC interval distribution s
baseline, 1,072 events; DHPG, 1,913 events.
(C) Representative AMPAR-dependent mEPSC traces from a neuron expressin
exposure. (i) mEPSC amplitude distributions from the same cell as in (C). Inset, su
exposure. (ii) Cumulative mEPSC amplitude distribution summarizing data from S
(iii) Cumulative mEPSC interval distribution summarizing data from the same cells
events.
(D) Representative AMPAR-dependent mEPSC traces from a neuron expressing
(i) mEPSC amplitude distributions from the same cell as in (D). Note the larger
expressing Scr shRNA in (Ci). Inset, superimposed averagemEPSCwaveforms re
distribution summarizing data from Triad3-shRNA expressing cells in control solu
summarizing data from the same cells as (ii). ***p < 0.0001. Data are from five ce
aligned on the rise and are averages of 100mEPSCs for each condition. Statistical
three independent experiments.
(E) Bar graphs summarizing the effects of DHPG onmEPSCs from cells expressing
mean mEPSC amplitude (p = 0.000141). Right, graph plotting mean increase in
mEPSC amplitude and interval.
(F) Bar graphs summarizing the effects of DHPG on mEPSCs from cells express
plotting reduction in mean mEPSC amplitude (p = 0.03212). Right, graph plottin
nificance was measured using an unpaired t test. Data represent means ± SEM
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